The Daily Star April 27, 2003 An antidote to arsenic patients! Bangladeshi scientists find remedy for chronic arsenic poisoning patients Naimul Haq An experimental preparation called (VMS6) containing a blend of six vitamins and minerals has been found to be safe and useful in the treatment of patients with chronic arsenic poisoning in Bangladesh. Scientists who carried out the research claimed that the discovery would save millions of lives suffering from arsenic poisoning. This was disclosed to the Star Health last week by the president of Bangladesh Arsenic Control Society (BACS). In a fifteen months of painstaking trial the scientists of the society carried out a double-blind clinical trial among 330 adult patients in Hajiganj upazilla in Chandpur district, with support from the government and the Unicef. The results were remarkable and the scientists term the discovery as a 'break-through' in the history of modern science. Dr Golam Hasan Rabbani, an senior researcher at the most reputed research centre - ICDDR,B who is also the director of the project under which the research was carried out said that it is the first scientific evidence showing successful treatment using vitamins and minerals including vitamin C, E, beta carotene, selenium, folic acid, and zinc. Dr Rabbani pointed out, "The findings will not only be useful for arsenic-affected patients of Bangladesh but millions of patients in Taiwan, China, Mexico, Argentina, Chile, USA, and India where large scale arsenic poisoning have also been reported but Bangladeshis would benefit from the discovery most as the magnitude of the problem is manifold here" Dr Rabbani continued, "The importance of this experimental study has been recognised internationally by the Global Health Council and I have been invited to present the findings in its Annual Conference in Washington DC, USA next month (26-30 May 2003)." The magic pill! In this study, each patient was given two caplets of VMS6 daily for six months and then on alternate months for another six months (total 12 months) along with arsenic-free water using simple two-bucket Sono water filter. Laboratory analyses were carried out at the same time at the Intronics Laboratory in Dhaka in collaboration with Wagner College, City University, New York. The mean age of patients were 42.2 years, most patients were malnourished and were exposed to arsenic for 4 - 8 years. The highest concentrations of arsenic in drinking water was 1400 parts per billion (ppb) with a mean of 619 ppb, most of the arsenic in water is in the inorganic form (AsIII and AsV) and the maximum level of arsenic allowed in drinking water by Bangladesh standard is 50 ppb. The findings indicate that daily intake of two VMS6 caplets for 12 months significantly increased arsenic elimination through urine. In the body VMS6 enhances the chemical breakdown of arsenic into less toxic products such as MMA and DMA which are increasingly eliminated through the urine. Because of urinary elimination, arsenic contents in hair and nail tissue are also reduced by 2-3 folds in 12 months. The results show that Bangladeshi patients excrete less arsenic in urine and retain more in the body because of poor ability to convert (methylation) arsenic into less toxic MMA and DMA due to malnutrition and protein deficiency. In these patients, treatment with VMS6 significantly increases MMA /DMA contents in urine by stimulating methylation or the process of breaking down of the toxic arsenic into less toxic elements. Thus VMS6 would be useful in for patients to eliminate arsenic from the body through urine. These observations indicate that arsenic toxicity can not be fully cured by giving arsenic-free water alone, as believed by many scientists. For better effects it needs to be supplemented with antioxidant agents such as vitamins and minerals. Dr Rabbani explained, "A combination of vitamin-minerals and arsenic-free water could be an important strategy for arsenic mitigation in Bangladesh. However, more studies will be needed to determine the best combination of vitamins, their doses, and duration of treatment. The effect of treatment in reducing the risks of long-term complications such as cancers need to be determined. Once the product is scientifically validated, it can be recommended for general use." Professor S M Keramat Ali, Professor M Alauddin (from New York), Dr H K Das, Dr Afzal Hossain, Dr P K Sengupta, Dr M Nasir, Moyenul Islam, and Dr S K Saha were co-researchers who also took part in the same study mostly spending time in the village.